Altshuler David
CIK 0001550395 Name as filed on the most recent filing
Filed as Altshuler David (89)
229 transaction lines · from 89 filings · filed 2014-08-01 to 2025-05-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
229 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-08-08 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 146 disposed | 295.14 | 43,090.44 | Form 4, filing 0000899243-22-028246 | |
| 2022-07-19 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 6,604 disposed | 289.48 | 1,911,725.92 | Form 4, filing 0000899243-22-026486 | |
| 2022-07-19 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 5,737 disposed | 288.67 | 1,656,099.79 | Form 4, filing 0000899243-22-026486 | |
| 2022-07-19 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 4,561 disposed | 287.83 | 1,312,792.63 | Form 4, filing 0000899243-22-026486 | |
| 2022-07-19 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 963 disposed | 286.72 | 276,111.36 | Form 4, filing 0000899243-22-026486 | |
| 2022-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 3,188 disposed | 230.62 | 735,216.56 | Form 4, filing 0000899243-22-008109 | |
| 2022-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2,784 disposed | 231.64 | 644,885.76 | Form 4, filing 0000899243-22-008109 | |
| 2022-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,040 disposed | 229.41 | 238,586.40 | Form 4, filing 0000899243-22-008109 | |
| 2022-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 560 disposed | 232.68 | 130,300.80 | Form 4, filing 0000899243-22-008109 | |
| 2022-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,303 disposed | 230.05 | 299,755.15 | Form 4, filing 0000899243-22-007203 | |
| 2022-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,038 disposed | 233.27 | 242,134.26 | Form 4, filing 0000899243-22-007203 | |
| 2022-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 986 disposed | 229.22 | 226,010.92 | Form 4, filing 0000899243-22-007203 | |
| 2022-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 600 disposed | 231.85 | 139,110.00 | Form 4, filing 0000899243-22-007203 | |
| 2022-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 385 disposed | 231.01 | 88,938.85 | Form 4, filing 0000899243-22-007203 | |
| 2022-02-14 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2,444 disposed | 232.02 | 567,056.88 | Form 4, filing 0001209191-22-010175 | |
| 2022-02-11 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 841 disposed | 233.92 | 196,726.72 | Form 4, filing 0001209191-22-009232 | |
| 2022-02-11 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 757 disposed | 234.95 | 177,857.15 | Form 4, filing 0001209191-22-009232 | |
| 2022-02-11 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 601 disposed | 236.28 | 142,004.28 | Form 4, filing 0001209191-22-009232 | |
| 2022-02-11 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 98 disposed | 237.23 | 23,248.54 | Form 4, filing 0001209191-22-009232 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,099 disposed | 253.41 | 278,497.59 | Form 4, filing 0001209191-22-006757 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 980 disposed | 251.22 | 246,195.60 | Form 4, filing 0001209191-22-006757 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 900 disposed | 252.10 | 226,890.00 | Form 4, filing 0001209191-22-006757 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 754 disposed | 249.97 | 188,477.38 | Form 4, filing 0001209191-22-006757 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 500 disposed | 247.73 | 123,865.00 | Form 4, filing 0001209191-22-006757 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 300 disposed | 254.46 | 76,338.00 | Form 4, filing 0001209191-22-006757 | |
| 2022-02-02 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 127 disposed | 248.65 | 31,578.55 | Form 4, filing 0001209191-22-006757 | |
| 2021-11-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 20 disposed | 187.51 | 3,750.20 | Form 4, filing 0001209191-21-064731 | |
| 2021-11-15 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 14 disposed | 186.80 | 2,615.20 | Form 4, filing 0001209191-21-064731 | |
| 2021-05-17 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 56 disposed | 216.31 | 12,113.36 | Form 4, filing 0001209191-21-033983 | |
| 2021-05-17 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 15 disposed | 217.13 | 3,256.95 | Form 4, filing 0001209191-21-033983 | |
| 2021-05-17 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 8 disposed | 215.31 | 1,722.48 | Form 4, filing 0001209191-21-033983 | |
| 2021-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,348 disposed | 213.05 | 287,191.40 | Form 4, filing 0001209191-21-014679 | |
| 2021-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 680 disposed | 214.28 | 145,710.40 | Form 4, filing 0001209191-21-014679 | |
| 2021-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 646 disposed | 211.58 | 136,680.68 | Form 4, filing 0001209191-21-014679 | |
| 2021-02-25 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 354 disposed | 216.26 | 76,556.04 | Form 4, filing 0001209191-21-014679 | |
| 2021-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 4,513 disposed | 211.84 | 956,033.92 | Form 4, filing 0001209191-21-012320 | |
| 2021-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 2,033 disposed | 212.59 | 432,195.47 | Form 4, filing 0001209191-21-012320 | |
| 2021-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,079 disposed | 210.11 | 226,708.69 | Form 4, filing 0001209191-21-012320 | |
| 2021-02-18 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 200 disposed | 213.26 | 42,652.00 | Form 4, filing 0001209191-21-012320 | |
| 2021-02-11 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 4,783 disposed | 210.42 | 1,006,438.86 | Form 4, filing 0001209191-21-010691 | |
| 2021-02-11 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 500 disposed | 211.67 | 105,835.00 | Form 4, filing 0001209191-21-010691 | |
| 2020-11-16 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 18 disposed | 223.57 | 4,024.26 | Form 4, filing 0001209191-20-059051 | |
| 2020-11-16 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 10 disposed | 224.32 | 2,243.20 | Form 4, filing 0001209191-20-059051 | |
| 2020-11-16 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 10 disposed | 222.45 | 2,224.50 | Form 4, filing 0001209191-20-059051 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 490 disposed | 270.12 | 132,358.80 | Form 4, filing 0001209191-20-045930 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 423 disposed | 271.39 | 114,797.97 | Form 4, filing 0001209191-20-045930 | |
| 2020-08-06 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 310 disposed | 272.60 | 84,506.00 | Form 4, filing 0001209191-20-045930 | |
| 2020-08-03 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 1,167 disposed | 278.14 | 324,589.38 | Form 4, filing 0001209191-20-045095 | |
| 2020-08-03 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 605 disposed | 279.19 | 168,909.95 | Form 4, filing 0001209191-20-045095 | |
| 2020-08-03 |
Vertex Pharmaceuticals Inc / MA VRTX |
S, Open-market sale | 458 disposed | 276.84 | 126,792.72 | Form 4, filing 0001209191-20-045095 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 229
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. ALTSHULER DAVID, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001550395
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6